亚太地区真皮填充剂市场预测至 2031 年 - 区域分析 - 按产品(可生物降解和不可生物降解)、材料(羟基磷灰石钙、透明质酸、胶原蛋白、聚-L-乳酸、聚甲基丙烯酸甲酯 (PMMA)、脂肪填充剂等)、应用(面部线条矫正治疗、唇部增强、面部提升、疤痕治疗等)和最终用户(多专科医院、皮肤科诊所、门诊手术中心等)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031


No. of Pages: 93    |    Report Code: TIPRE00025324    |    Category: Life Sciences

Asia Pacific Dermal Fillers Market
2023 年亚太地区真皮填充剂市场价值为 8.5498 亿美元,预计到 2031 年将达到 17.5783 亿美元;预计 2023 年至 2031 年的复合年增长率为 9.4%。

可支配收入增加和中产阶级人口扩大推动亚太地区真皮填充剂市场发展

根据欧盟的数据,到 2030 年,全球中产阶级人口将超过 53 亿。大部分增长可能会在亚洲持续。到 2030 年,中国和印度预计将占全球中产阶级人口的 65% 左右。不断扩大的中产阶级预计将促进经济发展并改变消费者行为和消费模式。随着可支配收入的增加、技术的变化和更好的后期护理,人们对美容和皮肤相关疾病的态度发生了变化,治疗程序和家庭医疗设备的采用也有所增加。此外,由于产品反响积极,美容和护肤行业的跨国公司明确瞄准了庞大的印度人口和不断增长的中产阶级。因此,可支配收入的增加可能会推动美容设备的采用率,为市场增长提供有利可图的机会。

亚太地区真皮填充剂市场概览

亚太地区真皮填充剂市场预计将在 2023 年至 2031 年期间以高复合年增长率增长。由于真皮填充剂越来越受欢迎以及医疗旅游业的发展,中国和日本的市场预计将快速增长。在中国,真皮填充剂在各种公立和私立医院中越来越受欢迎。由于可支配收入的提高和对外表的关注,这一数字进一步增加。此外,由于人口老龄化、收入增加和负担能力提高,印度正在成为真皮填充剂的增长市场之一。

亚太真皮填充剂市场收入及预测至 2031 年(百万美元)

亚太真皮填充剂市场细分

亚太真皮填充剂市场分为产品、材料、应用、最终用户和国家。

根据产品,亚太真皮填充剂市场分为可生物降解和不可生物降解两大类。可生物降解部分在 2023 年占据了更大的市场份额。

就材料而言,亚太真皮填充剂市场分为羟基磷灰石钙、透明质酸、胶原蛋白、聚-l-乳酸、聚甲基丙烯酸甲酯 (PMMA)、脂肪填充剂等。透明质酸细分市场在 2023 年占据了最大的市场份额。

按应用划分,亚太真皮填充剂市场细分为面部线条矫正治疗、唇部增强、面部提升、疤痕治疗等。唇部增强细分市场在 2023 年占据了最大的市场份额。

按最终用户划分,亚太真皮填充剂市场细分为多专科医院、皮肤科诊所、门诊手术中心等。皮肤科诊所细分市场在 2023 年占据了最大的市场份额。

按国家划分,亚太真皮填充剂市场细分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。2023 年,中国占据了亚太真皮填充剂市场的主导份额。

AbbVie Inc;BIOPLUS CO., LTD.;BIOXIS pharmaceuticals;Galderma SA; Merz Pharma GmbH & Co KGaA;Prollenium Medical Technologies;Sinclair Pharma Ltd;Suneva Medical;和 TEOXANE LABORATORIES 是亚太地区真皮填充剂市场的一些领先公司。

Asia Pacific Dermal Fillers Strategic Insights

Strategic insights for Asia Pacific Dermal Fillers involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-dermal-fillers-market-strategic-framework.webp
Get more information on this report

Asia Pacific Dermal Fillers Report Scope

Report Attribute Details
Market size in 2023 US$ 854.98 Million
Market Size by 2031 US$ 1,757.83 Million
Global CAGR (2023 - 2031) 9.4%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 产品
  • 可生物降解,不可生物降解
By 材料
  • 羟基磷灰石钙
  • 透明质酸
  • 胶原蛋白
  • 聚-L-乳酸
  • 聚甲基丙烯酸甲酯
  • 脂肪填充剂
By 应用
  • 面部线条矫正治疗
  • 唇部整形
  • 面部拉皮
  • 疤痕治疗
By 最终用户
  • 多专科医院
  • 皮肤科诊所
  • 门诊手术中心等
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • AbbVie Inc
  • BIOPLUS CO., LTD.
  • BIOXIS pharmaceuticals
  • Galderma SA
  • Merz Pharma GmbH & Co KGaA
  • Prollenium Medical Technologies
  • Sinclair Pharma Ltd
  • Suneva Medical
  • TEOXANE LABORATORIES
  • Get more information on this report

    Asia Pacific Dermal Fillers Regional Insights

    The regional scope of Asia Pacific Dermal Fillers refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-dermal-fillers-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Dermal Fillers Market

    1. AbbVie Inc                                        
    2. BIOPLUS CO., LTD.                                
    3. BIOXIS pharmaceuticals              
    4. Galderma SA                                  
    5. Merz Pharma GmbH & Co KGaA       
    6. Prollenium Medical Technologies             
    7. Sinclair Pharma Ltd                                        
    8. Suneva Medical                                         
    9. TEOXANE LABORATORIES                
    Frequently Asked Questions
    How big is the Asia Pacific Dermal Fillers Market?

    The Asia Pacific Dermal Fillers Market is valued at US$ 854.98 Million in 2023, it is projected to reach US$ 1,757.83 Million by 2031.

    What is the CAGR for Asia Pacific Dermal Fillers Market by (2023 - 2031)?

    As per our report Asia Pacific Dermal Fillers Market, the market size is valued at US$ 854.98 Million in 2023, projecting it to reach US$ 1,757.83 Million by 2031. This translates to a CAGR of approximately 9.4% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Dermal Fillers Market report typically cover these key segments-

  • 产品 (可生物降解,不可生物降解)
  • 材料 (羟基磷灰石钙, 透明质酸, 胶原蛋白, 聚-L-乳酸, 聚甲基丙烯酸甲酯, 脂肪填充剂)
  • 应用 (面部线条矫正治疗, 唇部整形, 面部拉皮, 疤痕治疗)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Dermal Fillers Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Dermal Fillers Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
  • Who are the major players in Asia Pacific Dermal Fillers Market?

    The Asia Pacific Dermal Fillers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • AbbVie Inc
  • BIOPLUS CO., LTD.
  • BIOXIS pharmaceuticals
  • Galderma SA
  • Merz Pharma GmbH & Co KGaA
  • Prollenium Medical Technologies
  • Sinclair Pharma Ltd
  • Suneva Medical
  • TEOXANE LABORATORIES
  • Who should buy this report?

    The Asia Pacific Dermal Fillers Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Dermal Fillers Market value chain can benefit from the information contained in a comprehensive market report.